Literature DB >> 22872452

Recurrence in giant cell tumour of bone: imaging features and risk factors.

Cheng-Sheng Wang1, Jiang-Hua Lou, Jin-Sheng Liao, Xiao-Yi Ding, Lian-Jun Du, Yong Lu, Ling Yan, Ke-Min Chen.   

Abstract

PURPOSE: This study was done to investigate X-ray, computed tomography (CT) and magnetic resonance (MR) imaging features of recurrence in giant cell tumour of bone (GCTB) and to evaluate risk factors.
MATERIALS AND METHODS: Medical records and imaging data were reviewed for 55 cases of recurrent GCTB. All images were reviewed retrospectively and independently by two radiologists experienced in skeletal musculature. The common radiological findings; factors related to tumour recurrence such as gender, age, location; pathological fracture, Campanacci grading and surgical procedure were analysed by nonparametric test (Mann-Whitney U test for two independent samples test and Kruskal-Wallis H test for multiple independent samples test). p values <0.05 were considered to indicate a statistically significant difference.
RESULTS: The imaging features of recurrent GCTB were as follows: osteolytic destruction or bone resorption of graft bone or around the polymethylmethacrylate (PMMA), soft tissue mass formation and expansile change. Tumour parenchyma showed markedly heterogeneous enhancement, except for necrotic cystic cavities, on contrast-enhanced MR images. Wide resection had a smaller (p=0.031) risk of local recurrence than did intralesional curettage. There was no statistical significance in gender, age, location, pathological fracture and Campanacci staging (p>0.05).
CONCLUSIONS: The risk of recurrence in GCTB was influenced by the type of surgery and adjuvants. Bone transformaresorption, soft tissue mass formation and aggravated expansile change are reliable signs of recurrence on imaging.

Entities:  

Mesh:

Year:  2012        PMID: 22872452     DOI: 10.1007/s11547-012-0860-4

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  19 in total

1.  Impact severity of local recurrence in giant cell tumor of bone.

Authors:  Richard L McGough; Janie Rutledge; Valerae O Lewis; Patrick P Lin; Alan W Yasko
Journal:  Clin Orthop Relat Res       Date:  2005-09       Impact factor: 4.176

2.  Giant-cell tumor: a study of 195 cases.

Authors:  D C Dahlin; R E Cupps; E W Johnson
Journal:  Cancer       Date:  1970-05       Impact factor: 6.860

3.  Intralesional excision compared with en bloc resection for giant-cell tumors of bone.

Authors:  S Gitelis; B A Mallin; P Piasecki; F Turner
Journal:  J Bone Joint Surg Am       Date:  1993-11       Impact factor: 5.284

4.  Late recurrence of giant-cell tumor of bone. A report of four cases.

Authors:  S P Scully; M P Mott; H T Temple; R J O'Keefe; R J O'Donnell; H J Mankin
Journal:  J Bone Joint Surg Am       Date:  1994-08       Impact factor: 5.284

5.  Recurrent giant cell tumor of long bones: analysis of surgical management.

Authors:  Frank M Klenke; Doris E Wenger; Carrie Y Inwards; Peter S Rose; Franklin H Sim
Journal:  Clin Orthop Relat Res       Date:  2010-09-16       Impact factor: 4.176

6.  Aggressive giant cell tumour of bone.

Authors:  W I Faisham; W Zulmi; A S Halim; B M Biswal; S S Mutum; A M Ezane
Journal:  Singapore Med J       Date:  2006-08       Impact factor: 1.858

7.  Conservative treatment of Campanacci grade III proximal humerus giant cell tumors.

Authors:  Richard D Lackman; Eileen A Crawford; Joseph J King; Christian M Ogilvie
Journal:  Clin Orthop Relat Res       Date:  2008-11-06       Impact factor: 4.176

8.  Giant-cell tumor of the appendicular skeleton.

Authors:  Michelle A Ghert; Marco Rizzo; John M Harrelson; Sean P Scully
Journal:  Clin Orthop Relat Res       Date:  2002-07       Impact factor: 4.176

9.  Favourable results of acrylic cementation for giant cell tumors.

Authors:  B M Persson; L Ekelund; R Lövdahl; B Gunterberg
Journal:  Acta Orthop Scand       Date:  1984-04

10.  Giant-cell tumor of bone.

Authors:  M Campanacci; N Baldini; S Boriani; A Sudanese
Journal:  J Bone Joint Surg Am       Date:  1987-01       Impact factor: 5.284

View more
  13 in total

1.  Histopathological, immunohistochemical, and image analytic parameters characterizing the stromal component in primary and recurrent giant cell tumor of bone.

Authors:  Charu Chandra Saxena; Rajni Safaya; Neha Kawatra Madan; Shah Alam Khan; Venkateswaran K Iyer
Journal:  J Clin Orthop Trauma       Date:  2015-10-26

2.  A prospective study on predicting local recurrence of giant cell tumour of bone by evaluating preoperative imaging features of the tumour around the knee joint.

Authors:  Yifeng He; Jun Wang; Ji Zhang; Fei Yuan; Xiaoyi Ding
Journal:  Radiol Med       Date:  2017-03-07       Impact factor: 3.469

3.  Giant cell tumor of temporomandibular joint masquerading as temporomandibular joint pain dysfunction syndrome: a rare case report.

Authors:  Jo Ee Sam; Rullyandrianto Pan Nuriman Rachmat; Cri Saiful Jordan Melano; Nasser Abdul Wahab
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2017-04-25

4.  A case of thoracic giant cell tumor of bone and discussion of radiological features and current management practices.

Authors:  Deirdre Kelly; Sarah Mc Erlean; Danielle Byrne; Peter Mac Mahon; John Mc Caffrey
Journal:  Radiol Case Rep       Date:  2016-05-25

5.  Retrospective investigation of "paint brush borders" sign in association with local recurrence of giant cell tumor of bone after intralesional curettage.

Authors:  Yifeng He; Jun Wang; Weiwei Rui; Juiming Lin; Fei Yuan; Lianjun Du; Ji Zhang; Xiaoyi Ding
Journal:  J Bone Oncol       Date:  2017-11-27       Impact factor: 4.072

6.  Preoperative CT for prediction of local recurrence after curettage of giant cell tumor of bone.

Authors:  Lenian Zhou; Shanyi Lin; Hanqiang Jin; Zhaoyuan Zhang; Changqing Zhang; Ting Yuan
Journal:  J Bone Oncol       Date:  2021-05-11       Impact factor: 4.072

7.  Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.

Authors:  Dongqi Li; Jinlei Zhang; Yi Li; Junfeng Xia; Yihao Yang; Mingyan Ren; Yedan Liao; Shunling Yu; Xiaojuan Li; Yan Shen; Ya Zhang; Zuozhang Yang
Journal:  World J Surg Oncol       Date:  2016-04-19       Impact factor: 2.754

8.  Denosumab for Treatment of a Recurrent Cervical Giant-Cell Tumor.

Authors:  Daisuke Kajiwara; Hiroto Kamoda; Tsukasa Yonemoto; Shintaro Iwata; Takeshi Ishii; Toshinori Tsukanishi; Seiji Ohtori; Masashi Yamazaki; Akihiko Okawa
Journal:  Asian Spine J       Date:  2016-06-16

9.  Soft tissue recurrence of giant cell tumor of the bone: Prevalence and radiographic features.

Authors:  Leilei Xu; Jing Jin; Annan Hu; Jin Xiong; Dongmei Wang; Qi Sun; Shoufeng Wang
Journal:  J Bone Oncol       Date:  2017-09-20       Impact factor: 4.072

10.  Prognostic Value of Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio, and Lymphocyte-to-White Blood Cell Ratio in Colorectal Cancer Patients Who Received Neoadjuvant Chemotherapy.

Authors:  Wangqiang Jia; Long Yuan; Hongyan Ni; Benling Xu; Peng Zhao
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.